# Total Occlusion Study in Coronary Arteries - 5

> **NCT01753180** · PHASE2 · COMPLETED · sponsor: **Matrizyme Pharma Corporation** · enrollment: 76 (actual)

## Conditions studied

- Chronic Coronary Total Occlusions

## Interventions

- **BIOLOGICAL:** collagenase
- **DRUG:** saline

## Key facts

- **NCT ID:** NCT01753180
- **Lead sponsor:** Matrizyme Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-12
- **Final completion:** 2016-07
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2016-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01753180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01753180, "Total Occlusion Study in Coronary Arteries - 5". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01753180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*